Merck KGaA (MKGAF.PK) to Invest E13 Million in Israeli Biomed Incubator
3/31/2011 7:22:58 AM
Globes -- Merck KGaA of Germany, which deals in chemicals and development of pharmaceuticals, and is traded in Frankfurt and on Nasdaq, is about to set up a biomed incubator in Israel, at its Israeli development center InterLab. Merck's biotech division, Merck-Serono, will invest €10 million in the venture over seven years.
comments powered by